Vuillemenot A - Search Results

1

[Complications of thrombolytic therapy in pulmonary embolism].

Meneveau N, Vuillemenot A, Bassand JP. Meneveau N, et al. Among authors: vuillemenot a. Arch Mal Coeur Vaiss. 1995 Nov;88(11 Suppl):1769-76. Arch Mal Coeur Vaiss. 1995. PMID: 8815838 Review. French.

2

[Subcutaneous recombinant hirudin in the treatment of deep venous thrombosis. A pharmacokinetic study].

Schiele F, Vuillemenot A, Mouhat T, Kramarz P, Kieffer Y, Camez A, Bassand JP. Schiele F, et al. Among authors: vuillemenot a. Arch Mal Coeur Vaiss. 1995 Mar;88(3):329-35. Arch Mal Coeur Vaiss. 1995. PMID: 7487286 French.

3

[Long-term outcome of subvalvular aortic stenoses. A comparative study in adults and children].

Bernard Y, Anguenot T, Meneveau N, Vuillemenot A, Schiele F, Bassand JP. Bernard Y, et al. Among authors: vuillemenot a. Arch Mal Coeur Vaiss. 1996 May;89(5):579-85. Arch Mal Coeur Vaiss. 1996. PMID: 8758566 French.

4

[Severe pulmonary embolism: value of clinical findings and complementary investigations].

Vuillemenot A, Meneveau N, Bassand JP. Vuillemenot A, et al. Arch Mal Coeur Vaiss. 1995 Nov;88(11 Suppl):1745-54. Arch Mal Coeur Vaiss. 1995. PMID: 8815835 Review. French.

5

Streptokinase vs alteplase in massive pulmonary embolism. A randomized trial assessing right heart haemodynamics and pulmonary vascular obstruction.

Meneveau N, Schiele F, Vuillemenot A, Valette B, Grollier G, Bernard Y, Bassand JP. Meneveau N, et al. Among authors: vuillemenot a. Eur Heart J. 1997 Jul;18(7):1141-8. doi: 10.1093/oxfordjournals.eurheartj.a015410. Eur Heart J. 1997. PMID: 9243149 Clinical Trial.

6

Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: immediate clinical and hemodynamic outcome and one-year follow-up.

Meneveau N, Schiele F, Metz D, Valette B, Attali P, Vuillemenot A, Grollier G, Elaerts J, Mossard JM, Viel JF, Bassand JP. Meneveau N, et al. Among authors: vuillemenot a. J Am Coll Cardiol. 1998 Apr;31(5):1057-63. doi: 10.1016/s0735-1097(98)00068-0. J Am Coll Cardiol. 1998. PMID: 9562007 Free article. Clinical Trial.

7

Efficacy of a synthetic pentasaccharide, a pure factor Xa inhibitor, as an antithrombotic agent--a pilot study in the setting of coronary angioplasty.

Vuillemenot A, Schiele F, Meneveau N, Claudel S, Donat F, Fontecave S, Cariou R, Samama MM, Bassand JP. Vuillemenot A, et al. Thromb Haemost. 1999 Feb;81(2):214-20. Thromb Haemost. 1999. PMID: 10063994 Clinical Trial.

8

Use of recombinant hirudin as antithrombotic treatment in patients with heparin-induced thrombocytopenia.

Schiele F, Vuillemenot A, Kramarz P, Kieffer Y, Anguenot T, Bernard Y, Bassand JP. Schiele F, et al. Among authors: vuillemenot a. Am J Hematol. 1995 Sep;50(1):20-5. doi: 10.1002/ajh.2830500105. Am J Hematol. 1995. PMID: 7668220

9

A pilot study of subcutaneous recombinant hirudin (HBW 023) in the treatment of deep vein thrombosis.

Schiele F, Vuillemenot A, Kramarz P, Kieffer Y, Soria J, Soria C, Camez A, Mirshahi MC, Bassand JP. Schiele F, et al. Among authors: vuillemenot a. Thromb Haemost. 1994 May;71(5):558-62. Thromb Haemost. 1994. PMID: 8091380 Clinical Trial.

10

[Deep venous thrombosis of the lower limbs. Etiology, physiopathology, diagnosis, course, prognosis, treatment].

Vuillemenot A, Bassand JP. Vuillemenot A, et al. Rev Prat. 1994 Jan 1;44(1):109-17. Rev Prat. 1994. PMID: 8178047 French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters